Prevalence of low serum folate and vitamin B12 in an older Australian population

Australian and New Zealand Journal of Public Health

Volumn 30, Issue 1, 2006, Pages 38-41

  Flood, Victoria M ^a   Smith, Wayne T ^b   Webb, Karen L ^a   Rochtchina, Elena ^a   Anderson, Valerie E ^c   Mitchell, Paul ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION DISTRIBUTION; PREVALENCE; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VITAMIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; AUSTRALIA; FEMALE; FOLIC ACID DEFICIENCY; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; VITAMIN B 12 DEFICIENCY;

EID: 33244496470     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.2006.tb00084.x     Document Type: Article

References (25)

1. Clarke R, Refsum H, Birks J, Evans JG, Johnston C, Sherliker P, et al. Screening for vitamin B-12 and folate deficiency in older persons. Am J Clin Nutr. 2003;77:1241-7.
2. Healton EB, Savage DG, Brust JCM, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine. 1991;70:229-44.
3. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J. 2002;325:1202.
4. Ravaglia G, Forti P, Maioli F, Muscari A, Sacchetti L, Arnone G, et al. Homocysteine and cognitive function in healthy elderly community dwellers in Italy. Am J Clin Nutr. 2003;77:668-73.
5. Cahill M, Karabatzaki M, Meleady R, Resum H, Ueland P, Shields D, et al. Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol. 2000;84:154-7.
6. van Asselt DZ, de Groot LC, Van Staveren WA, et al. Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am J Clin Nutr. 1998;68:328-34.
7. Lumley J, Watson L, Watson M, Bower C. Periconceptual supplementation with folate and/or multivitamins for preventing neural tube defects (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 4, 2000. Oxford (UK): Update Software; 2002.
8. Flood VM, Webb KL, Smith W, Mitchell P, Bantick JM, Macintyre R, et al. Folate fortification: potential impact on folate intake in an older population. Eur J Clin Nutr. 2001;55:793-800.
9. Lindenbaum J, Rosenberg IH, Wilson PW, Stabler SP, Allen RH. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr. 1994;60:2-11.
10. Green TJ, Venn BJ, Skeaff CM, Williams SM. Serum vitamin B12 concentrations and atrophic gastritis in older New Zealanders. Eur J Clin Nutr. 2005;59:205-10.
11. Foran S, Wang JJ, Mitchell P. Causes of visual impairment in two older population cross-sections: the Blue Mountains Eye Study. Ophthalmic Epidemiol. 2003;10:215-25.
12. Webb KL, Schofield WN, Lazarus R, Smith W, Mitchell P, Leeder SR. Prevalence and socio-demographic predictors of dietary goal attainment in an older population. Aust N Z J Public Health. 1999;23:578-84.
13. Selhub J, Jaques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, et al. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med.1999;131:331-9.
14. Green R, Kinsella LJ. Current concepts in the diagnosis of cobalamin deficiency. Neurology. 1995;45:1435-40.
15. Gibson R. Principles of Nutritional Assessment. 1st edition. New York (NY): Oxford University Press; 1990.
16. Robinson K, Arheart K, Refsum H, Brattsrom L, Boers G, Ueland P, et al. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAS Group. Circulation. 1998;97:437-43.
17. Savage DG, Lindenbaum J. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med. 1994;96:239-46.
18. Bjorkegren K, Svardsudd K. A population-based intervention study of elevated serum levels of methylmalonic acid and total homocysteine in elderly people: results after 36 months of follow-up. J Int Med. 2004;256:446-52.
19. Institute of Medicine. Dietary References for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin and Choline. Washington (DC): National Academy Press; 1998.
20. Shane B. Folate fortification: enough already? Am J Clin Nutr. 2003;77:8-9.
21. Mills JL, Von Kohorn I, Conley MR, Zeller JA, Cox C, Williamson RE, et al. Low vitamin B12 concentrations in patients without anaemia: the effect of folic acid fortification of grain. Am J Clin Nutr. 2003;77:1474-7.
22. Clarke R. Prevention of vitamin B-12 deficiency in old age. Am J Clin Nutr. 2001;73:151-2.
23. Herbert V, Biagaouette J. Call for endorsement of a petition to the Food and Drug Administration to always add vitamin B-12 to any folate fortification or supplement. Am J Clin Nutr. 1997;65:572-3.
24. Hvas A-M, Ellegaard J, Nexo E. Vitamin B12 treatment normalizes metabolic markers but has limited clinical effect: a randomised placebo-controlled study. Clin Chem. 2001;47:1396-404.
25. Hvas AM, et al. Vitamin B12 treatment has limited effect on health-related quality of life among individuals with elevated plasma methylmalonic acid: a randomized placebo-controlled study. J Int Med. 2003;253:146-52.